These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 19318217)

  • 1. Review of cardiovascular risk factors in women.
    Evangelista O; McLaughlin MA
    Gend Med; 2009; 6 Suppl 1():17-36. PubMed ID: 19318217
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trends in cardiovascular risk factors among U.S. men and women with and without diabetes, 1988-2014.
    Sun X; Du T
    BMC Public Health; 2017 Nov; 17(1):893. PubMed ID: 29166886
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Cardiovascular risk and cardiometabolic risk: an epidemiological evaluation].
    Vanuzzo D; Pilotto L; Mirolo R; Pirelli S
    G Ital Cardiol (Rome); 2008 Apr; 9(4 Suppl 1):6S-17S. PubMed ID: 18773746
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High prevalence of cardiometabolic risk factors in women considered low risk by traditional risk assessment.
    Pollin IS; Kral BG; Shattuck T; Sadler MD; Boyle JR; McKillop L; Campbell C; Ashen MD; Nasir K; Redberg RF; Brintzenhofeszoc K; Blumenthal RS; Michos ED
    J Womens Health (Larchmt); 2008; 17(6):947-53. PubMed ID: 18582174
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sex differences in cardiovascular risk factors and disease prevention.
    Appelman Y; van Rijn BB; Ten Haaf ME; Boersma E; Peters SA
    Atherosclerosis; 2015 Jul; 241(1):211-8. PubMed ID: 25670232
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low testosterone concentrations in men contribute to the gender gap in cardiovascular morbidity and mortality.
    Haring R; John U; Völzke H; Nauck M; Dörr M; Felix SB; Wallaschofski H
    Gend Med; 2012 Dec; 9(6):557-68. PubMed ID: 23182129
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is the impact of conventional risk factors the same in men and women? Plea for a more gender-specific approach.
    Cifkova R; Pitha J; Krajcoviechova A; Kralikova E
    Int J Cardiol; 2019 Jul; 286():214-219. PubMed ID: 30685102
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sex- and gender-related prevalence, cardiovascular risk and therapeutic approach in metabolic syndrome: A review of the literature.
    Pucci G; Alcidi R; Tap L; Battista F; Mattace-Raso F; Schillaci G
    Pharmacol Res; 2017 Jun; 120():34-42. PubMed ID: 28300617
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic interactions between cardiovascular risk factors.
    Vishram JK
    Dan Med J; 2014 Jul; 61(7):B4892. PubMed ID: 25123126
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gender differences in the metabolic syndrome and their role for cardiovascular disease.
    Regitz-Zagrosek V; Lehmkuhl E; Weickert MO
    Clin Res Cardiol; 2006 Mar; 95(3):136-47. PubMed ID: 16598526
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gender aspects of the role of the metabolic syndrome as a risk factor for cardiovascular disease.
    Regitz-Zagrosek V; Lehmkuhl E; Mahmoodzadeh S
    Gend Med; 2007; 4 Suppl B():S162-77. PubMed ID: 18156101
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comprehensive Evaluation of Type 2 Diabetes and Cardiovascular Disease Risk Profiles in Reproductive-Age Women with Polycystic Ovary Syndrome: A Large Canadian Cohort.
    Kazemi M; Pierson RA; Lujan ME; Chilibeck PD; McBreairty LE; Gordon JJ; Serrao SB; Zello GA; Chizen DR
    J Obstet Gynaecol Can; 2019 Oct; 41(10):1453-1460. PubMed ID: 30712903
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of age and sex with cardiovascular risk factors and insulin sensitivity in overweight children and adolescents.
    Koenigsberg J; Boyd GS; Gidding SS; Hassink SG; Falkner B
    J Cardiometab Syndr; 2006; 1(4):253-8. PubMed ID: 17679813
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of different definitions of the metabolic syndrome on the prevalence of organ damage, cardiometabolic risk and cardiovascular events.
    Mancia G; Bombelli M; Facchetti R; Casati A; Ronchi I; Quarti-Trevano F; Arenare F; Grassi G; Sega R
    J Hypertens; 2010 May; 28(5):999-1006. PubMed ID: 20308922
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men.
    Lakka HM; Laaksonen DE; Lakka TA; Niskanen LK; Kumpusalo E; Tuomilehto J; Salonen JT
    JAMA; 2002 Dec; 288(21):2709-16. PubMed ID: 12460094
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sex differences in pericardial adipose tissue assessed by PET/CT and association with cardiometabolic risk.
    Gill CM; Azevedo DC; Oliveira AL; Martinez-Salazar EL; Torriani M; Bredella MA
    Acta Radiol; 2018 Oct; 59(10):1203-1209. PubMed ID: 29444586
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Abdominal obesity and the spectrum of global cardiometabolic risks in US adults.
    Ghandehari H; Le V; Kamal-Bahl S; Bassin SL; Wong ND
    Int J Obes (Lond); 2009 Feb; 33(2):239-48. PubMed ID: 19050677
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of metabolic alterations predictive of cardiovascular disease risk in the Québec population.
    Scarsella C; Alméras N; Mauriège P; Blanchet C; Sauvé L; Dewailly E; Bergeron J; Després JP
    Can J Cardiol; 2003 Jan; 19(1):51-7. PubMed ID: 12571695
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 17.